Title:
ANTIBODY BINDING TO CLAUDIN-18.2 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/007808
Kind Code:
A1
Abstract:
The present disclosure relates to an antibody binding to claudin-18.2 and use thereof, or an antigen-binding portion thereof and use thereof. The antibody can bind to claudin-18.2 with high affinity, can be used for detecting the claudin-18.2, and can be used for diagnosing, treating or preventing diseases associated with cells of the claudin-18.2.
Inventors:
CHEN BO (CN)
WANG YING (CN)
WANG YING (CN)
Application Number:
PCT/CN2021/104819
Publication Date:
January 13, 2022
Filing Date:
July 06, 2021
Export Citation:
Assignee:
KEYMED BIOSCIENCES CO LTD (CN)
SHANGHAI LINGYUE BIOPHARMA CO LTD (CN)
SHANGHAI LINGYUE BIOPHARMA CO LTD (CN)
International Classes:
C07K16/30; A61K39/395; A61P35/00; C12N15/13; C12N15/63
Domestic Patent References:
| WO2014146672A1 | 2014-09-25 |
Foreign References:
| CN111777681A | 2020-10-16 | |||
| CN110606891A | 2019-12-24 | |||
| CN109762067A | 2019-05-17 | |||
| CN103509114A | 2014-01-15 |
Attorney, Agent or Firm:
MERITS & TREE (CN)
Download PDF:
Previous Patent: BISPECIFIC ANTIBODY AND USE THEREOF
Next Patent: NOVEL POLYPEPTIDE PREPARATION AND THERAPEUTIC USE THEREOF
Next Patent: NOVEL POLYPEPTIDE PREPARATION AND THERAPEUTIC USE THEREOF